Preferred Label : pirfenidone;

MeSH note : structure given in first source;

CISMeF synonym : deskar;

MeSH synonym : 5-methyl-1-phenyl-2-(1H)-pyridone;

MeSH hyponym : 1-phenyl-5-(trideuteriomethyl)-1,2-dihydropyridin-2-one;

MeSH Related Number : 53179-13-8 (pirfenidone); 1QC36BHI6S;

Registry Number MeSH : 53179-13-8;

Is substance : O;

UNII : D7NLD2JX7U;

InChIKey : ISWRGOKTTBVCFA-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3490837/fr/esbriet-pirfenidone-fibrose-pulmonaire-idiopathique-fpi-severe
2024
false
false
false
France
evaluation of the transparency committee
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
fibrosis of lung, nos
Severe Adverse Event
Pirfenidone
idiopathic pulmonary fibrosis
severe
esbriet
Severe Dysplasia
pirfenidone
unknown (origin)
Severe Hallucination
Idiopathic Pulmonary Fibrosis
Severe Extremity Pain
Intensity and Distress 5
pirfenidone

---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pirfenidone-aet
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
pirfenidone
pirfenidone
pirfenidone
drugs, generic

---
https://ansm.sante.fr/informations-de-securite/esbriet-pirfenidone-mise-a-jour-importante-de-securite-et-nouvelles-recommandations-concernant-les-risques-datteintes-hepatiques-dorigine-medicamenteuse
2020
false
false
false
France
French
risk
guidelines for drug use
pharmacovigilance note
pirfenidone
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
drug monitoring
liver function tests
pyridones

---
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
https://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73905a-fra.php
2020
false
false
false
Canada
French
English
pharmacovigilance note
pirfenidone
Chemical and Drug Induced Liver Injury
pirfenidone
liver function tests
drug monitoring
continuity of patient care
idiopathic pulmonary fibrosis
anti-inflammatory agents, non-steroidal
pyridones

---
https://www.has-sante.fr/portail/jcms/c_2803495/fr/esbriet
2017
false
false
false
France
French
evaluation of the transparency committee
esbriet
pirfenidone
pyridones

---
Progrès thérapeutique mineur dans le traitement de la fibrose pulmonaire idiopathique uniquement chez les patients ayant une CVF 50% une DLCO 30 %
http://www.has-sante.fr/portail/jcms/c_2023166/fr/esbriet
http://www.has-sante.fr/portail/jcms/c_2023166/fr/esbriet-pirfenidone-immunosuppresseur
2015
false
France
French
evaluation of the transparency committee
guidelines for drug use
pyridones
pyridones
pirfenidone
pirfenidone
administration, oral
orphan drug production
insurance, health, reimbursement
adult
idiopathic pulmonary fibrosis
treatment outcome
randomized controlled trials as topic
clinical trials, phase iii as topic
meta-analysis as topic
pirfenidone

---
http://www.meddispar.fr/Medicaments/ESBRIET-267-B-63/(type)/letter/(value)/E/(cip)/3400941688317
http://www.meddispar.fr/Medicaments/ESBRIET-267-B-252/%28type%29/letter/%28value%29/E/%28cip%29/3400941688485
2014
false
false
false
drug information
administration, oral
drug prescriptions
legislation, drug
pirfenidone
pirfenidone
idiopathic pulmonary fibrosis
continuity of patient care
capsules
pyridones

---
http://www.prescrire.org/Fr/3/31/48283/0/NewsDetails.aspx
2013
idiopathic pulmonary fibrosis
pirfenidone

---
https://www.ema.europa.eu/medicines/human/EPAR/Esbriet
2013
false
United Kingdom
French
English
syndication feed
pyridones
pirfenidone
pirfenidone
pyridones
drug approval
treatment outcome
administration, oral
adult
idiopathic pulmonary fibrosis
orphan drug production
drug interactions
pregnancy
breast feeding
anti-inflammatory agents, non-steroidal
anti-inflammatory agents, non-steroidal
drug evaluation, preclinical
pirfenidone
drug evaluation
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_1251583/esbriet-pirfenidone-immunosuppresseur
http://www.has-sante.fr/portail/jcms/c_1238454/esbriet
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
pirfenidone
pirfenidone
pirfenidone
idiopathic pulmonary fibrosis
adult
administration, oral
orphan drug production
insurance, health, reimbursement
pyridones
pyridones
treatment outcome
meta-analysis as topic
clinical trials, phase iii as topic
risk management

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00213
2012
false
false
false
Canada
pirfenidone
pirfenidone
Product containing pirfenidone (medicinal product)
drug information
pyridones

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.